ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

ICCM IceCure Medical Ltd

1,12
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:57:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IceCure Medical Ltd ICCM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 1,12 10:57:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,12
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/5/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202414:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
15/4/202414:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
03/4/202414:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
03/4/202413:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
02/4/202414:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
27/3/202413:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
19/3/202413:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
12/3/202413:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
07/3/202414:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
04/3/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202414:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
27/2/202414:00PRNUSFourth BRIIT Conference in India Features IceCure's..
26/2/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202414:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
15/2/202414:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
30/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202414:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
29/1/202414:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
16/1/202414:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
12/1/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
10/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
03/1/202414:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
13/12/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202314:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
29/11/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202314:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
28/11/202314:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
15/11/202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202314:00PRNUSIceCure Medical Reports Financial Results as of and for the..
15/11/202313:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
08/11/202314:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
06/11/202314:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
03/11/202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202321:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
30/10/202313:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
25/10/202314:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
05/10/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202314:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
02/10/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202314:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
22/9/202314:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
20/9/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202313:00PRNUSIceCure Medical Receives FDA Response to De Novo..
08/9/202314:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
05/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..